Vanderbilt Vaccine Center Archives
Jul. 18, 2013—Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.
May. 16, 2013—Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.
Feb. 21, 2013—A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.
Dec. 6, 2012—Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades.
Jan. 5, 2012—Human rhinovirus (HRV), also known as the common cold, can be uncommonly serious for certain children, a study led by a Vanderbilt University Medical Center pediatrician shows. The study, published in the Dec. 28, 2011 online issue of the journal Pediatrics, shows that not only can HRV lead to hospitalization in very low birth weight...